Delivery Order SPE2DB24D8002-SPE2DB24FJMRV
Award Date
8/1/24
Potential Completion Date
8/2/24
Potential Value
$9.1K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award with the ID SPE2DB24D8002|SPE2DB25FJMVJ was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,758.11 firm fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of December 9, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant $999,999,999.00 Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $7,570.36, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support the medical supply chain needs of the U.S. Department of Defense. The contract has a completion date of December 1, 2023, and is a Firm Fixed Price Delivery Order. Dakota Drug, Inc. also holds a larger Indefinite Delivery Contract...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2WM8, was made to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to the U.S. Department of Defense's Defense Logistics Agency (DLA). The contract has a firm fixed price and a ceiling value of $5,524.42. It is a delivery order contract with a performance period ending on May 31, 2024. Dakota Drug, Inc. is a key supplier to the DLA...
This federal contract award, identified as SPE2DB24D8001|SPE2DB25FKZEP, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,034.86, is a Firm Fixed Price Delivery Order for the provision of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract is not set-aside and has an ultimate completion date of February 12, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DX15D8001|SPE2DX24FBQXN, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,834.67 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through May 13, 2024. Dakota Drug, Inc. is a critical vendor for the DLA's medical supply chain, holding a substantial...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has a ceiling value of $15,991.71 and a period of performance through January 15, 2025. This delivery order was placed under Dakota Drug's existing $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which is part of the DLA Troop Support...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract, identified as SPE2DX15D8003|SPE2DX24F7E4R, has a total ceiling value of $2,088.72 and a completion date of July 1, 2024. It is a Firm Fixed Price Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division. Dakota Drug, Inc. is a key supplier of pharmaceutical and...
This federal contract award, identified as SPE2DB24D8003 and SPE2DB25FJTDX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product Trelegy Ellipta, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has a ceiling value of $4,079.19 and a completion date of October 21, 2024. This award is not associated with any...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The contract, identified as SPE2DX15D8002|SPE2DX24F2TZ7, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,443.60 and an ultimate completion date of December 5, 2023. Dakota Drug, Inc. is a key supplier of...
The U.S. Defense Logistics Agency (DLA) awarded a $6,399.12 firm-fixed-price delivery order to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide 4566343564 units of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical product. This delivery order falls under Dakota Drug's existing indefinite delivery contract (IDC) SPE2DB24D8001, valued at $999,999,999.00, which supports the DLA Troop Support Medical's ECAT Generation V Program. The contract has an ultimate completion date...